TrkA-IN-6 (compound R48) is a hydrazone-based, selective inhibitor of the tropomyosin receptor kinase A (TrkA). It exhibits greater cytotoxicity towards U87 GBM cells compared to Temozolomide, with an IC50 of 68.99 µM.
Formula:
C16H13N3O5
Target:
Trk receptor
* VAT and and shipping costs not included. Errors and price changes excepted
